Zobrazeno 1 - 6
of 6
pro vyhledávání: '"TTR (Time in Therapeutic Range)"'
Autor:
Martin van Zyl, Robert D. McBane, Ana I. Casanegra, Thomas M. Jaeger, Bernard J. Gersh, Waldemar E. Wysokinski
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 5, Pp 511-520 (2020)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 5, Pp 511-520 (2020)
Objective To evaluate differences in time in therapeutic range (TTR), major bleeding, thromboembolism, and survival comparing in-home and in-clinic international normalized ratio monitoring for patients with mechanical heart valves receiving warfarin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70ffb24dd26108583c4e9c15d2136df2
https://doi.org/10.1016/j.mayocpiqo.2020.05.003
https://doi.org/10.1016/j.mayocpiqo.2020.05.003
Publikováno v:
EBioMedicine
EBioMedicine, Vol 4, Iss C, Pp 26-39 (2016)
EBioMedicine, Vol 4, Iss C, Pp 26-39 (2016)
Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the corn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be05c5dae5f0604c3964605ca1316ca0
http://europepmc.org/articles/PMC4776061
http://europepmc.org/articles/PMC4776061
Autor:
Laget, Cécile
Les patients en fibrillation auriculaire (FA) présentant des facteurs de risque thromboembolique sont éligibles au traitement anticoagulant par antivitamines K (AVK). Leur utilisation est difficile du fait d’une marge thérapeutique étroite et l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::b90448f86c2086fa72262b92c64c4b28
https://dumas.ccsd.cnrs.fr/dumas-01080504
https://dumas.ccsd.cnrs.fr/dumas-01080504
Autor:
van Zyl M; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Wysokinski WE; Division of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Jaeger TM; Division of Community Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Casanegra AI; Division of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., Gersh BJ; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN., McBane RD 2nd; Division of Vascular Medicine, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Publikováno v:
Mayo Clinic proceedings. Innovations, quality & outcomes [Mayo Clin Proc Innov Qual Outcomes] 2020 Aug 15; Vol. 4 (5), pp. 511-520. Date of Electronic Publication: 2020 Aug 15 (Print Publication: 2020).
Autor:
Voukalis C; University of Birmingham, Institute of Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK., Lip GY; University of Birmingham, Institute of Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK., Shantsila E; University of Birmingham, Institute of Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, UK.
Publikováno v:
EBioMedicine [EBioMedicine] 2016 Jan 15; Vol. 4, pp. 26-39. Date of Electronic Publication: 2016 Jan 15 (Print Publication: 2016).
Autor:
Chilipko AA; MedStar Union Memorial Hospital, Baltimore, Maryland., Norwood DK; MedStar Union Memorial Hospital, Baltimore, Maryland.
Publikováno v:
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists [Consult Pharm] 2014 Feb; Vol. 29 (2), pp. 95-103.